Decreased clot burden is associated with factor XIII Val34Leu polymorphism and better functional outcomes in acute ischemic stroke patients treated with intravenous thrombolysis.

Szegedi, István; Orbán-Kálmándi, Rita; Nagy, Attila; Sarkady, Ferenc; Vasas, Nikolett; Sik, Máté; Lánczi, Levente István; Berényi, Ervin; Oláh, László; CriÈan, Alexandra; Csiba, László; Bagoly, Zsuzsa

Szegedi, István; Orbán-Kálmándi, Rita; Nagy, Attila; Sarkady, Ferenc; Vasas, Nikolett; Sik, Máté; Lánczi, Levente István; Berényi, Ervin; Oláh, László; CriÈan, Alexandra; Csiba, László; Bagoly, Zsuzsa.

Afiliación

Szegedi I; Department of Neurology, Faculty of Medicine, Doctoral School of Neuroscience, University of Debrecen, Debrecen, Hungary.
Orbán-Kálmándi R; Division of Clinical Laboratory Sciences, Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Nagy A; Department of Preventive Medicine, Faculty of Public Health, University of Debrecen, Debrecen, Hungary.
Sarkady F; Division of Clinical Laboratory Sciences, Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Vasas N; Department of Radiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Sik M; Department of Radiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Lánczi LI; Department of Radiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Berényi E; Department of Radiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Oláh L; Department of Neurology, Faculty of Medicine, Doctoral School of Neuroscience, University of Debrecen, Debrecen, Hungary.
CriÈan A; Department of Neurology, City Hospital of Odorheiu-Secuiesc, Odorheiu Secuiesc, Romania.
Csiba L; Department of Neurology, Faculty of Medicine, Doctoral School of Neuroscience, University of Debrecen, Debrecen, Hungary.
Bagoly Z; ELKH-DE Cerebrovascular and Neurodegenerative Research Group, Debrecen, Hungary.

PLoS One ; 16(7): e0254253, 2021.

Article en En | MEDLINE | ID: mdl-34234378

Asunto(s)

Factor XIII/genética; Fibrinolíticos/administración & dosificación; Accidente Cerebrovascular Isquémico/tratamiento farmacológico; Accidente Cerebrovascular Isquémico/genética; Polimorfismo Genético/genética; Trombosis/tratamiento farmacológico; Administración Intravenosa; Anciano; Estudios de Casos y Controles; Femenino; Fibrinógeno/genética; Fibrinólisis/efectos de los fármacos; Fibrinólisis/genética; Humanos; Masculino; Persona de Mediana Edad; Estudios Prospectivos; Terapia Trombolítica/métodos; Trombosis/genética; Activador de Tejido Plasminógeno/genética; Resultado del Tratamiento

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Polimorfismo Genético / Trombosis / Factor XIII / Fibrinolíticos / Accidente Cerebrovascular Isquémico Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: Hungria

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google